Target
Cav-1
1 abstract
Abstract
Phase II trial of biologically optimized schedule of gemcitabine and nab-paclitaxel in metastatic pancreatic cancer.Org: The Ohio State University Comprehensive Cancer Center and Department of Internal Medicine, Center for Biostatistics, Department of Biomedical Informatics,